Inhibition of Innate Immune Responses of Polymorphonuclear Leucocytes and Monocytes by Rhinacanthin‑C by Dahima, Rashmi
Dahima                                                                                                                       Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):40-42 
ISSN: 2250-1177                                                                                  [40]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.06.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
Inhibition of Innate Immune Responses of Polymorphonuclear Leucocytes 
and Monocytes by Rhinacanthin‑C 
Dahima Rashmi* 
School of Pharmacy, Devi Ahilya Vishwavidyalaya, Takshashila Campus, Khandwa Road, Indore-452001, M.P., India 
 
ABSTRACT 
Phagocytosis is a pivotal microbicidal function of innate immune cells by which phagocytes would engulf and eliminate invading pathogens. The 
functioning and efficacy of immune system is altered by many pathogens e.g. bacteria and fungi and the nonspecific kind of innate immunity is 
responsible for providing protection against these invading pathogens. The aim of this study is to assess the inhibitory effect of rhinacanthin‑C 
on phagocytic activities to obtain important insights into its ability to suppress phagocytes. Phagocytosis activity of innate immune cell was 
monitored using a flowcytometer and myeloperoxidase activity assay was conducted using a myeloperoxidase activity colorimetric assay. 
Rhinacanthin‑C at 100.0 and 6.25 μg/ml significantly showed strong inhibition of phagocytosis with percentage of 26.40% and 30.59% 
respectively, in comparison with the positive control (p< 0.001). A dose-dependent (50.0, 25.0, 12.5, 6.25 and 3.13 μg/ml) inhibition of MPO 
activity of rhinacanthin-C was observed and show high activity compared to control cells (p< 0.001). This finding indicated that rhinacanthin-C 
was able to suppress human phagocyte response and emphasizing their potency as immunomodulatory agents. Nevertheless, further  
investigations are needed to elucidate other immunomodulatory responses. 
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INTRODUCTION 
Immune system is responsible for maintaining homeostasis 
within the body of host. An agent, synthetic or natural that 
has the potency to suppress or improve both specific and 
non-specific immunological responses, is termed as 
immunomodulator. The functioning and efficacy of immune 
system is altered by many pathogens e.g. bacteria and fungi 
and the nonspecific kind of innate immunity is responsible 
for providing protection against these invading pathogens1. 
Components of innate immune system viz monocytes, 
macrophages and polymorphonuclear leucocytes (PMNs), 
performance essential role to eradicate the pathogens2. Upon 
infection, these professional phagocytic cells accumulate at 
the site of infection and engulf the invaders causing their 
destruction. Through the activation of myeloperoxidase 
(MPO) and nicotinamide adenine dinucleotide phosphate-
oxidase (NADPH) stimulated phagocytes release reactive 
oxygen species (ROS)3. Under normal situation, ROS are 
known to participate in destruction of pathogens, which have 
been considered as the most efficient microbicide 
mechanisms. Beside their defensive purpose during 
infections, overproduction of ROS can promote the 
inflammatory process. It also contributes in the development 
of various diseases including rheumatoid disorders4. 
Therefore, it needs to discover the inhibitors of reactive 
oxidants production for the treatment of inflammation. 
Recently, there is a great interest in investigating medicinal 
plants having potency in modulating the immune system. 
Many bioactive compounds derived from medicinal plants 
such as curcumin, codifolioside A, syringin, phyllantin and 
hypophyllantin exhibited immunomodulatory activity5,6. 
Rhinacanthus nasutus, a medicinal herb native to Thailand 
and Southeast Asia, has traditionally been used in the 
treatment of various disorders including diabetes mellitus7. 
In China and Taiwan it has been consumed as an herbal 
drink8. Rhinacanthin‑C, a major phytochemical of 
Rhinacanthus nasutus leaf has been recently reported for 
some pharmacological activities like antibacterial, antifungal, 
antiproliferative, anti-inflammatory, antidiabetic and 
hyperlipidemic and pancreatic protection effects in diabetic 
rats9. However, no information is available about the activity 
of rhinacanthin‑C in modulating phagocytosis of innate 
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immune response. The aim of this study is to assess the 
inhibitory effect of rhinacanthin‑C on phagocytic activities to 
obtain important insights into its ability to suppress 
phagocytes. 
MATERIALS AND METHODS 
Chemicals and solutions 
Rhinacanthin‑C (purity ≥98%) was isolated in our laboratory 
from green leaves of Rhinacanthus nasutus as per the method 
described by Bhushal et al. (2014)10. Indomethacin (purity 
>99%) was purchased from Sigma Aldrich (Sigma-Aldrich 
Chemicals Pvt. Ltd. Bengaluru, India). All other drugs were 
dissolved in distilled water. The doses for all freshly 
prepared drug solutions were expressed in terms of their 
free bases. 
Isolation of polymorphonuclear leucocytes and monocytes 
The PMNs isolation was conducted as described previously 
by Septama et al. (2018)11. Fresh goat blood was obtained 
from the authorized slaughterhouse. Briefly, the blood was 
mixed with the mixture of PBS and dextran (1:1) and left for 
sedimentation at 25 °C for 45 min. PMNs were isolated by 
centrifugation on Ficoll density gradient and washed with 
distilled water. PMNs were then collected from the base of 
the tubes. A modified method was used to isolate 
monocytes12. The blood was mixed with physiological 
solution in an equal volume. The mixture was then carefully 
added with lymphoprep and centrifuged (400 × g, 45 min). 
Monocytes were retained at the medium interface, removed 
and washed with PBS (250 × g for 10 min) and re-suspended 
in PBS. The cells suspensions were then counted using 
heamocytometer and light microscope, then diluted with PBS 
to adjust approximately 1 × 106 cells/ml. 
Phagocytosis assay 
Phagocytosis activity of innate immune cell was monitored 
using a flowcytometer. Briefly, 20 μl samples of 
rhinacanthin‑C (6.25 and 100.0 μg/ml) and 100 μl whole 
blood were incubated with 20 μl FITC-labelled opsonized 
Escherichia coli for 30 min in shaking water bath (60 
rpm/min). Positive control was cells without samples. While 
cell remained on ice was used as a negative control. After 
incubation, tubes were immediately kept on ice to stop 
phagocytosis and added with quenching solution. The cells 
were then mixed with 2 ml of lysing solution and incubated 
at room temperature for 20 min. After that, the cells were 
washed with PBS and then re-suspended in 200 μl DNA 
staining solution. Phagocytosis was observed using 
flowcytometer. Percentage of phagocytosis was considered 
as phagocytic activity11. 
Myeloperoxidase activity assay 
The assay was conducted using a myeloperoxidase activity 
colorimetric assay kit (OxiSelect) Briefly, PMNs suspensions 
(1 × 106 cells/ml) were incubated with samples at final 
concentrations of 50.0, 25.0, 12.5, 6.25 and 3.13 μg/ml, at 37 
°C for 10 min. The cells were then activated with PMA (8 × 
10-7 M) and incubated at 37 °C, 30 min. After that, the cells 
were centrifuged (450 × g, 10 min). The supernatants were 
collected to determine MPO activity. Indometachin was used 
as a positive control. Supernatant obtained from PMA 
stimulated neutrophil without treatment was considered as 
100% of MPO release. Fifty μl supernatant of samples, 
positive control and normal control were added into 96-
wells plate, then 50 μl of reaction mix (40 μl MPO buffer 
assay + 10 μl MPO substrate) was added to each well. While, 
50 μl of the sample background control (40 μl MPO buffer 
assay + 10 μl dH2O) was added to background control (PBS). 
The mixture was then incubated at 25 °C for 30 min. Two 
microlitre stop mix were added to all samples, positive 
control, normal control and background control and 
incubated for 10 min to stop reaction. Fifty μl TNB standard 
was added 50 μl to all wells. Then, the reading was taken 
using microplate reader at 412 nm. 
Statistical analysis 
Results were expressed as mean ± S.E.M. The data were 
analyzed by one way analysis of variance (ANOVA) tracked 
by Tukey's multiple comparison tests. Probability values less 
than 0.05 were considered statistically significant in all the 
cases. 
RESULTS AND DISCUSSION 
Phagocytosis is a pivotal microbicidal function of innate 
immune cells by which phagocytes would engulf and 
eliminate invading pathogens. Many receptors are competent 
to initiate engulfment of opsonized bacteria. Fcc receptors, 
such as FccRII and FccRIII will bind to 
immunoglobulincoated particles, while complement-
opsonized bacteria are recognized by CR1 (CD35) and CR3 
(CD11b)13. The effect of rhinacanthin‑C on phagocytosis was 
analyzed by flowcytometer. Rhinacanthin‑C at 100.0 and 
6.25 μg/ml significantly showed strong inhibition with 
percentage of phagocytosis of 26.40% and 30.59% 
respectively, in comparison with the positive control (p< 
0.001). Positive control was the untreated cells at 37 °C in 
which condition phagocytes enabled to engulf opsonized 
bacteria. Normal condition at 0 °C was used a negative 
control. Phagocytosis is essential for effective control of 
infection. Killing invading bacteria by neutrophil may be 
critical point of the outcome of inflammation. The result 
indicates that flavonoids were able to inhibit phagocytosis. 
This result was supported by a previous work which 
reported the inhibitory effect of phytoconstituents like 
artocarpin and artocarpanone on phagocytosis activity 
against invading bacteria11 (Table 1). 
Myeloperoxidase is a haemic enzyme expressed in PMNs. 
Upon stimulation by phorbol myristate acetate (PMA), PMNs 
release MPO, which catalyze the production of hypochlorous 
acid (HClO), as an important microbicide agent. However, in 
some inflammation conditions, MPO released induce severe 
damage to cell membrane and host tissue14. Therefore, 
reducing the activity of MPO might be beneficial to the 
treatment of inflammation. A dose-dependent inhibition of 
MPO activity of rhinacanthin-C was observed and show high 
activity compared to control cells (p< 0.001) (Figure 1). The 
result exhibited the potency of rhinacanthin-C to reduce the 
deleterious effect of MPO and is supported by several 
studies. According to previous works, epigallocatechin 
gallate, eriodictyol, artocarpanone and artocarpin inhibited 
MPO activity in human neutrophil11, hence the presented 
research is supported by previous works which reported the 
inhibitory effect of phytoconstituents on MPO. 
Table 1: Percentage phagocytic activity of 
rhinacanthin‑C on phagocytes. 
Sample Percent phagocytic activity 
 100.0 μg/ml 6.25 μg/ml 
Positive control 72.86 ± 0.93 - 
Rhinacanthin-C 26.40 ± 0.17* 30.59 ± 0.14* 
Negative control 20.95 ± 0.12 - 
Results are expressed as Mean ± S.E.M. (n = 3). Data was analyzed by 
one way repeat measure ANOVA followed by Tukey’s multiple 
comparison test. Significance: *p< 0.001 when compared with 
positive control group. Positive control was normal cells incubated 
at 37 °C and negative control was normal cells incubated on ice        
(0 °C). 
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Figure 1: Percentage inhibition of myeloperoxidase activity by rhinacanthin-C in polymorphonuclear leucocytes.  
Results are expressed as Mean ± S.E.M. (n = 3). Data was analyzed by one way repeat measure ANOVA followed by Tukey’s multipl e comparison 
test. Significance: *p< 0.001 when compared with respective control. 
 
CONCLUSIONS 
In conclusion, rhinacanthin-C exhibited strong inhibitory 
effects at different steps of phagocytosis. This finding 
indicated that rhinacanthin-C was able to suppress human 
phagocyte response and emphasizing their potency as 
immunomodulatory agents. Nevertheless, further 
investigations are needed to elucidate other 
immunomodulatory responses. 
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